Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Faehling

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|August 12, 2006
[Persistent CK-elevation after CSE inhibitor therapy]M Faehling, M Leschke
Advances in Experimental Medicine and Biology|January 1, 1997
Heterogeneity of beta-cell secretion. Possible involvement of K-ATP channelsM Faehling, F M Ashcroft
Diabetologia|March 4, 1999
High affinity binding sites for proinsulin on human umbilical vein endothelial cells (HUVEC)M Faehling, R D Fussgaenger, P M Jehle
Der Internist|July 11, 2009
[Diagnostics in pulmonary hypertension]M Leschke, A Wädlich, S Waldenmaier, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2003
[Is there a connection between tooth diseases and diseases in a healthy heart?]K Brodbeck-Stoll, M Faehling, M Leschke
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
[Impaired glucose metabolism in patients with ischaemic heart disease]M Leschke, B Schwenk, C Bollinger, et al.
The International Journal of Biochemistry & Cell Biology|April 20, 2001
Vascular endothelial growth factor-A activates Ca2+ -activated K+ channels in human endothelial cells in cultureM Faehling, E D Koch, J Raithel, et al.
Lung|October 8, 2005
Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblastsM Hetzel, M Bachem, D Anders, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 29, 2011
Successful pregnancy complicated by persistent pneumothorax in a patient with lymphangioleiomyomatosis (LAM) on sirolimusM Faehling, S Frohnmayer, M Leschke, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2013
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survivalM Faehling, R Eckert, T Kamp, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|August 12, 2006
[Persistent CK-elevation after CSE inhibitor therapy]M Faehling, M Leschke
Advances in Experimental Medicine and Biology|January 1, 1997
Heterogeneity of beta-cell secretion. Possible involvement of K-ATP channelsM Faehling, F M Ashcroft
Diabetologia|March 4, 1999
High affinity binding sites for proinsulin on human umbilical vein endothelial cells (HUVEC)M Faehling, R D Fussgaenger, P M Jehle
Der Internist|July 11, 2009
[Diagnostics in pulmonary hypertension]M Leschke, A Wädlich, S Waldenmaier, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2003
[Is there a connection between tooth diseases and diseases in a healthy heart?]K Brodbeck-Stoll, M Faehling, M Leschke
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
[Impaired glucose metabolism in patients with ischaemic heart disease]M Leschke, B Schwenk, C Bollinger, et al.
The International Journal of Biochemistry & Cell Biology|April 20, 2001
Vascular endothelial growth factor-A activates Ca2+ -activated K+ channels in human endothelial cells in cultureM Faehling, E D Koch, J Raithel, et al.
Lung|October 8, 2005
Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblastsM Hetzel, M Bachem, D Anders, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 29, 2011
Successful pregnancy complicated by persistent pneumothorax in a patient with lymphangioleiomyomatosis (LAM) on sirolimusM Faehling, S Frohnmayer, M Leschke, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2013
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survivalM Faehling, R Eckert, T Kamp, et al.
Pageof 2